Reuters US Business

By Mrinalika Roy, Christy Santhosh and Tom Hals (Reuters) -Pfizer and Novo Nordisk’s fight for obesity drug developer Metsera ratcheted up on Tuesday, as both companies submitted sweetened bids, with Metsera saying Novo’s $10 billion offer is superior. The dramatic bidding war kicked off last week with Novo’s surprise play for Metsera, which had already …

Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera Read More »

By Kenneth Li (Reuters) – Thomson Reuters reported higher third-quarter revenue on Tuesday, boosted by investments in artificial intelligence products in its legal and tax and accounting divisions. The Toronto-based content and technology company also reaffirmed its full-year 2025 guidance of a 7% to 7.5% rise in organic revenue, which tracks income from existing businesses …

Thomson Reuters revenue rises in third quarter, reaffirms 2025 forecast Read More »

By Fabian Cambero SANTIAGO (Reuters) -Chile’s Codelco, the world’s largest copper producer, cut on Tuesday its forecast for 2025 output, despite higher production in the year’s first nine months through September. The state-owned miner lowered its copper production guidance to 1.31 million to 1.34 million metric tons this year, from a prior estimate of 1.34 …

Chile’s Codelco cuts copper output guidance for 2025 despite higher production through September Read More »

WILMINGTON, Del. (Reuters) -There is currently no need for a court to grant Pfizer’s request to get involved in its bidding war with Novo Nordisk for Metsera , a Delaware judge said at an emergency hearing on Tuesday. However, Vice Chancellor Morgan Zurn of Delaware’s Court of Chancery scheduled a hearing for 3:15 p.m. EST …

Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo Read More »

(Reuters) -Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 million to develop an experimental cancer therapy. Under the terms of the agreement, Blackstone’s drug development unit will fund a portion of the development costs to test sac-TMT, an experimental antibody-drug conjugate. Antibody-drug …

Merck secures $700 million funding from Blackstone to develop cancer therapy Read More »

By Puyaan Singh and Sahil Pandey (Reuters) -Medical equipment distributor Henry Schein raised its annual profit forecast after beating Wall Street estimates for third-quarter results on Tuesday, driven by strong sales in its dental and medical units. Shares of the Melville, New York-based company were up 7.4%, after it announced a cost saving plan which …

Henry Schein lifts annual forecast on strong dental, medical equipment sales Read More »

By Doyinsola Oladipo and David Shepardson NEW YORK/WASHINGTON (Reuters) -Airport security screeners working without pay during the U.S. government shutdown are in a stronger financial position than they were during the last prolonged closure in 2019, thanks to improvements in pay and benefits. Airport delays have begun to worsen as they did during Donald Trump’s …

US airport security TSA workers ride out shutdown with better pay, benefits than in 2019 Read More »

By Deborah Mary Sophia (Reuters) -Shopify on Tuesday projected strong revenue growth for the crucial holiday shopping season, as sellers on its platform benefited from consumer demand defying U.S. import tariffs and price hikes. While the tariffs have strained retailers heading into the holiday season, merchants are still spending on Shopify’s e-commerce tools thanks to …

Shopify expects strong holiday revenue, costs dent quarterly margins Read More »